Research map: Shared evidence, different recommendations: a comparative analysis of Qdenga (TAK-003) dengue vaccine guidance for travellers across countries

Back to the article

Papers in this map

  1. Antibody-dependent enhancement of severe dengue disease in humans · Leah C. Katzelnick · 2017 · 1286 citations · Cited by this paper
  2. The cycle of recurrence: why Ebola persists in an era of countermeasure abundance · 2026 · Related
  3. Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy · Saranya Sridhar · 2018 · 817 citations · Cited by this paper
  4. Patterns of antibiotic prescription and use for travellers’ diarrhoea among travellers · 2026 · Related
  5. Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents · Shibadas Biswal · 2019 · 417 citations · Cited by this paper
  6. Evidence that ginger ( Zingiber officinale ) does not prevent motion sickness in adults · 2026 · Related
  7. Adaptive immune responses to primary and secondary dengue virus infections · Ashley L. St. John · 2019 · 343 citations · Cited by this paper
  8. Measles mumps rubella (MMR) vaccination status in international paediatric travellers seen for pre-travel consultation in Minnesota, USA · 2026 · Related
  9. Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial · Vianney Tricou · 2024 · 261 citations · Cited by this paper
  10. Plasmodium falciparum infections and number needed to screen among refugees arriving from sub-Saharan Africa · 2026 · Related
  11. Qdenga® - A promising dengue fever vaccine; can it be recommended to non-immune travelers? · Martin Angelin · 2023 · 80 citations · Cited by this paper
  12. Dengue in the high Himalayas: new challenges for travel medicine · 2026 · Related
  13. Immune status alters the probability of apparent illness due to dengue virus infection: Evidence from a pooled analysis across multiple cohort and cluster studies · Hannah Clapham · 2017 · 73 citations · Cited by this paper
  14. Border measures may delay but rarely prevent early dominance of local transmission: imported-to-local patterns across public health emergencies of international concern · 2026 · Related
  15. Causes of fever in returning travelers: a European multicenter prospective cohort study · Daniel Camprubí-Ferrer · 2022 · 73 citations · Cited by this paper
  16. International risk of secondary hantavirus clusters following MV Hondius outbreak · 2026 · Related
  17. The increasing complexity of arbovirus serology: An in-depth systematic review on cross-reactivity · Louella M.R. Kasbergen · 2023 · 56 citations · Cited by this paper
  18. Growing cross-border hospitalization needs at the China–Myanmar border · 2026 · Related
  19. Epidemiology of travel-associated dengue from 2007 to 2022: A GeoSentinel analysis · Alexandre Duvignaud · 2024 · 49 citations · Cited by this paper
  20. Comparison of NITAG policies and working processes in selected developed countries · Walter Ricciardi · 2014 · 47 citations · Cited by this paper
  21. A new dengue vaccine (TAK-003) now WHO recommended in endemic areas; what about travellers? · David O. Freedman · 2023 · 47 citations · Cited by this paper
  22. A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country · Vianney Tricou · 2023 · 30 citations · Cited by this paper
  23. Clinical Characteristics and Outcomes Among Travelers With Severe Dengue · Ralph M. H. G. Huits · 2023 · 27 citations · Cited by this paper
  24. Novel chikungunya and dengue vaccines: travel medicine applications · Robert J. Steffen · 2024 · 22 citations · Cited by this paper
  25. Dengue Vaccine Development and Deployment into Routine Immunization · Annelies Wilder‐Smith · 2025 · 21 citations · Cited by this paper
  26. Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults · Inge Lefevre · 2023 · 20 citations · Cited by this paper
  27. Dengue virus infection among long-term travelers from the Netherlands: A prospective study, 2008-2011 · Femke W. Overbosch · 2018 · 19 citations · Cited by this paper
  28. Consistency of immunogenicity in three consecutive lots of a tetravalent dengue vaccine candidate (TAK-003): A randomized placebo-controlled trial in US adults · Vianney Tricou · 2023 · 17 citations · Cited by this paper
  29. Prognosis and mortality risk in elderly patients with dengue virus infection: Excess fatality and the urgent need for revising current WHO criteria for elderly patients · Min-Jia Jeng · 2025 · 17 citations · Cited by this paper
  30. Dengue severity in travellers: challenges and insights · Sarah L. McGuinness · 2023 · 15 citations · Cited by this paper
  31. Vaccination perspectives: the Qdenga® dilemma · Rachael Fletcher · 2025 · 13 citations · Cited by this paper
  32. Streamlining malaria prevention recommendations for travellers: current and future approaches · Sarah L. McGuinness · 2024 · 10 citations · Cited by this paper
  33. The Path Forward for Vaccine Policy in the United States · Helen Y. Chu · 2025 · 8 citations · Cited by this paper
  34. Dengue virus infection in travellers after dengue vaccination, Germany 2023–24 · Raskit Lachmann · 2025 · 5 citations · Cited by this paper
  35. Dengue and aging: challenges and opportunities in prevention and care. A narrative review · Alessia Beccacece · 2026 · 5 citations · Cited by this paper
  36. Towards national guidance on dengue and chikungunya vaccination in travellers: Lessons from global recommendations · Anna Bogacka · 2026 · 4 citations · Cited by this paper
  37. The Tolerability of the Dengue Vaccine TAK-003 (Qdenga®) in German Travelers: The Results of a Prospective Survey · Tomáš Jelı́nek · 2025 · 3 citations · Cited by this paper
  38. The US Advisory Committee on Immunization Practices (ACIP): trustworthy travel vaccine guidance and politics · Lin Hwei Chen · 2025 · 2 citations · Cited by this paper
  39. Dengue in a warming world: changing epidemiology, vaccines, and therapeutic developments · Francesca F. Norman · 2026 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)